Cargando…

Correlate tumor mutation burden with immune signatures in human cancers

BACKGROUND: Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response and cancer prognosis. Although many explorations have revealed that high TMB may yield many neoantigens to incite antitumor immune response, a systematic exploration of the correlation between TMB and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaosheng, Li, Mengyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329192/ https://www.ncbi.nlm.nih.gov/pubmed/30634925 http://dx.doi.org/10.1186/s12865-018-0285-5

Ejemplares similares

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data
por: Li, Mengyuan, et al.
Publicado: (2023)

Cell cycle activity correlates with increased anti‐tumor immunity in diverse cancers
por: Jiang, Shanmei, et al.
Publicado: (2020)

Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment
por: Jiang, Zehang, et al.
Publicado: (2019)

Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer()
por: Jiang, Zehang, et al.
Publicado: (2018)

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023)

Identification of Transcriptional Signatures of Colon Tumor Stroma by a Meta-Analysis
por: Uddin, Md. Nazim, et al.
Publicado: (2019)

Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
por: Liu, Qian, et al.
Publicado: (2021)

ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer
por: Li, Lin, et al.
Publicado: (2019)

Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients
por: Xiang, Li, et al.
Publicado: (2022)

Tumor mutational burden and immune signatures interplay in renal cell carcinoma
por: Yakirevich, Evgeny, et al.
Publicado: (2020)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation
por: Fu, Jing, et al.
Publicado: (2021)

KALRN mutations promote antitumor immunity and immunotherapy response in cancer
por: Li, Mengyuan, et al.
Publicado: (2020)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Computational analysis of expression of human embryonic stem cell-associated signatures in tumors
por: Wang, Xiaosheng
Publicado: (2011)

Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer
por: Liu, Ning, et al.
Publicado: (2022)

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

Transcriptional landscape of human cancers
por: Li, Mengyuan, et al.
Publicado: (2017)

An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients
por: Guo, Wenbing, et al.
Publicado: (2020)

Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2021)

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
por: Pham, Timothy V., et al.
Publicado: (2020)

Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer
por: Wu, Zonglong, et al.
Publicado: (2020)

Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis
por: He, Yin, et al.
Publicado: (2020)

Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
por: van den Heuvel, Guus R. M., et al.
Publicado: (2021)

Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden
por: Raj, Shailaja K. S., et al.
Publicado: (2022)

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
por: Wang, Haoyu, et al.
Publicado: (2022)

Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients
por: Peng, Linglong, et al.
Publicado: (2021)

Determining mutational burden and signature using RNA-seq from tumor-only samples
por: Jessen, Erik, et al.
Publicado: (2021)

The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression
por: Zhang, Zhilan, et al.
Publicado: (2020)

DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer
por: Li, Man, et al.
Publicado: (2020)

Construction and Evaluation of a Tumor Mutation Burden-Related Prognostic Signature for Thyroid Carcinoma
por: Lu, Haodong, et al.
Publicado: (2021)

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer
por: Wei, Cheng, et al.
Publicado: (2022)

Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
por: Alsaihati, Burair A., et al.
Publicado: (2021)

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
por: Liu, Zijian, et al.
Publicado: (2020)

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
por: Zaravinos, Apostolos, et al.
Publicado: (2019)

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer
por: Yu, Jie, et al.
Publicado: (2021)

Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer
por: Xu, Lijun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_trgd189jri8ur824fh3ol9a2g5